We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Downregulation of the NLRP3/Caspse-1 Pathway Ameliorates Ketamine-Induced Liver Injury and Inflammation in Developing Rats.
- Authors
Chen, Xinzhang; Zhang, Zhiheng; Shen, Meilun; Ma, Xiangying; Qiu, Di; Li, Siyao; Gao, Li
- Abstract
Ketamine is an anesthetic drug that is widely used in human and veterinary medicine. In the developmental stage, long-term exposure to ketamine may cause serious side effects. MCC950 and VX765 play protective roles in many disease models by regulating the NLRP3/Caspase-1 pathway. This study aims to explore the potential protective effect of MCC950 and VX765 on ketamine-induced liver injury in neonatal rats and clarify its underlying mechanism. After administration of MCC950 and VX765 in a ketamine-induced liver injury rat model, liver function and inflammatory factors were determined, and immunohistochemistry and western blotting were performed. We found that ketamine caused liver injury in 7-day-old SD rats, decreased liver function indexes, and increased inflammation. MCC950 and VX765 effectively alleviated liver damage and inflammation, and downregulated the expression of proteins such as NLRP3, Caspase-1, and GSDMD-N. In summary, these results indicated that MCC950 and VX765 could have potential protective effects on ketamine-induced liver injury through inhibiting the NLRP3/Caspase-1 pathway.
- Subjects
LIVER injuries; WESTERN diet; NLRP3 protein; VETERINARY medicine; RATS; DOWNREGULATION; LIVER cells
- Publication
Molecules, 2022, Vol 27, Issue 9, p2931
- ISSN
1420-3049
- Publication type
Article
- DOI
10.3390/molecules27092931